No Data
No Data
Investors in Matrix Composites & Engineering (ASX:MCE) Have Seen Impressive Returns of 110% Over the Past Three Years
Everest Group Recognizes Foundever in 2024 PEAK Matrix for Americas
Merakris Therapeutics Introduces Dermacyte AC Matrix: A Lyophilized Amnion Chorion Allograft
Matrix Composites Announces New Share Quotation
Matrix Composites Started With A$0.44/Share Target Price by Morgans>MCE.AU
Matrix Composites & Engineering Started at Spec Buy by Morgans >MCE.AU
No Data
No Data